PI3K pathway inhibitors approach junction

被引：44
|
作者：
Holmes, David
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2011年 / 10卷 / 08期
关键词：
D O I：
10.1038/nrd3527
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：563 / 565
页数：3
相关论文
共 50 条
  • [31] The development of inhibitors of PI3K and Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [32] PI3K inhibitors in haematological malignancies
    Brown, Jennifer R.
    Danilov, Alexey V.
    LaCasce, Ann S.
    Davids, Matthew S.
    LANCET ONCOLOGY, 2022, 23 (08): : E364 - E364
  • [33] Clinical development of inhibitors of the PI3K
    Saura Manich, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Targeting the PI3K pathway in cancer
    Workman, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S80 - S80
  • [35] Targeting the PI3K pathway in cancer
    Mills, GB
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S4
  • [36] The PI3K Pathway in Human Disease
    Fruman, David A.
    Chiu, Honyin
    Hopkins, Benjamin D.
    Bagrodia, Shubha
    Cantley, Lewis C.
    Abraham, Robert T.
    CELL, 2017, 170 (04) : 605 - 635
  • [37] PI3K pathway in prostate cancer: All resistant roads lead to PI3K
    Park, Soonbum
    Kim, Young Sik
    Kim, Davis Yeon
    So, Insuk
    Jeon, Ju-Hong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 198 - 206
  • [38] PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations
    Chung, Wei-Pang
    Huang, Wei-Lun
    Lee, Chun-Hui
    Hsu, Hui-Ping
    Huang, Wan-Ling
    Liu, You-Yu
    Su, Wu-Chou
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3067 - +
  • [39] REDUCED CANCER CELL SENSITIVITY TO TUMOR TREATING FIELDS (TTFIELDS) THROUGH ACTIVATION OF THE PI3K/AKT/MTOR SIGNALING PATHWAY CAN BE MITIGATED USING PI3K INHIBITORS OR PI3K/MTOR DUAL INHIBITORS
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2021, 23 : 84 - 84
  • [40] Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
    Rodriguez-Freixinos, Victor
    Ruiz-Pace, Fiorella
    Farinas-Madrid, Lorena
    Garrido-Castro, Ana Christina
    Villacampa, Guillermo
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Oaknin, Ana
    ESMO OPEN, 2019, 4 (02)
12345